Enanta Pharmaceuticals
ENTA
#8260
Rank
NZ$0.59 B
Marketcap
NZ$20.52
Share price
-5.17%
Change (1 day)
13.20%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total assets

Total assets on the balance sheet as of June 2026 : NZ$0.52 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total assets are NZ$0.52 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Enanta Pharmaceuticals - Total assets on balance sheet (from 2011 to 2026)

Total assets by year

Year Total assets Change
2025-09-30NZ$0.48 B-18.4%
2024-09-30NZ$0.59 B-23.02%
2023-09-30NZ$0.77 B15.78%
2022-09-30NZ$0.66 B4.68%
2021-09-30NZ$0.63 B-13.32%
2020-09-30NZ$0.73 B-6.16%
2019-09-30NZ$0.78 B25.07%
2018-09-30NZ$0.62 B37.69%
2017-09-30NZ$0.45 B17.23%
2016-09-30NZ$0.38 B0.62%
2015-09-30NZ$0.38 B93.47%
2014-09-30NZ$0.19 B41.14%
2013-09-30NZ$0.14 B123.79%
2012-09-30NZ$63.01 M85.31%
2011-09-30NZ$34 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
NZ$357.24 B 67,626.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$216.82 B 41,006.54%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
NZ$240.07 B 45,413.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$48.72 B 9,137.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$230.63 B 43,623.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$155.70 B 29,419.32%๐Ÿ‡บ๐Ÿ‡ธ USA